This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a minimally invasive procedure used to diagnose and treat problems of the pancreas and bile ducts. It involves the insertion of a long, thin, flexible tube called an endoscope into the mouth, down the throat, and through the stomach and into the small intestine. Once the endoscope is in place, a small amount of contrast material is injected into the bile ducts and pancreatic ducts. As the contrast material passes through these ducts, X-ray images are taken so that any abnormalities can be seen. This includes blockages, tumors, stones, or even narrowing of the ducts. The doctor can then take action depending on what is seen. For example, if a blockage is seen, a stent can be placed to open it up. If a tumor is present, biopsy samples can be taken for further testing. In addition to diagnosing problems, ERCP can also be used to treat them. For example, if the bile ducts are blocked by a stone, the doctor can use a special device to break it up into small pieces and then remove them from the body. This relieves the obstruction, allowing the bile to flow freely again. ERCP is a highly effective procedure that can help diagnose and treat many problems of the digestive tract. It is safe and minimally invasive, with minimal risk of complications. However, it should only be performed by a qualified doctor, as incorrect or inappropriate use of the procedure can lead to serious complications.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States